Remdesivir (Danish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Remdesivir" in Danish language version.

refsWebsite
Global rank Danish rank
2nd place
13th place
447th place
2,134th place
43rd place
3rd place
low place
38th place
344th place
265th place
7th place
28th place
1,346th place
2nd place
141st place
low place

asahi.com

doi.org

  • Scavone C, Brusco S, Bertini M, Sportiello L, Rafaniello C, Zoccoli A, et al. (april 2020). "Current pharmacological treatments for COVID-19: what's next?". British Journal of Pharmacology. doi:10.1111/bph.15072.
  • Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. (22. maj 2020). "Remdesivir for the Treatment of Covid-19 – Preliminary Report". New England Journal of Medicine. doi:10.1056/NEJMoa2007764.
  • Hongchao Pan; Richard Peto; Quarraisha Abdool Karim; Marissa Alejandria; Ana Maria Henao-Restrepo; César Hernández García; Marie-Paule Kieny; Reza Malekzadeh; Srinivas Murthy; Marie-Pierre Preziosi; Srinath Reddy; Mirta Roses Periago; Vasee Sathiyamoorthy; John-Arne Røttingen; Soumya Swaminathan (15. oktober 2020), Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results, doi:10.1101/2020.10.15.20209817Wikidata Q100994445
  • Jon Cohen; Kai Kupferschmidt (27. oktober 2020), "The 'very, very bad look' of remdesivir, the first FDA-approved COVID-19 drug", Science, doi:10.1126/SCIENCE.ABF4549Wikidata Q101071902

dr.dk

fda.gov

nationalgeographic.com

nytimes.com

videnskab.dk

wikidata.org

  • Hongchao Pan; Richard Peto; Quarraisha Abdool Karim; Marissa Alejandria; Ana Maria Henao-Restrepo; César Hernández García; Marie-Paule Kieny; Reza Malekzadeh; Srinivas Murthy; Marie-Pierre Preziosi; Srinath Reddy; Mirta Roses Periago; Vasee Sathiyamoorthy; John-Arne Røttingen; Soumya Swaminathan (15. oktober 2020), Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results, doi:10.1101/2020.10.15.20209817Wikidata Q100994445
  • Jon Cohen; Kai Kupferschmidt (27. oktober 2020), "The 'very, very bad look' of remdesivir, the first FDA-approved COVID-19 drug", Science, doi:10.1126/SCIENCE.ABF4549Wikidata Q101071902